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Introduction
Complex regional pain syndrome (CRPS) is
a chronic and often disabling condition
that is seen in many patients seeking pain
management. The condition leaves
patients in excruciating pain that is
disproportionate to the inciting injury. In
addition, patients with this pain disorder
experience abnormal sensations such as
cold and heat allodynia, hyperalgesia,
edema, abnormal sudomotor activity and
trophic changes (Lee et al., 2015). CRPS
disproportionally affects four times as
many women as men (Alexander, Peterlin,
Perreault, Grothusen, & Schwartzman,
2012). There are two types of CRPS: type
1, often referred to as reflex sympathetic
dystrophy (RSD), is not evident of nerve
damage while type 2 does indicate nerve
damage. Figure 1 provided by Marinus et
al. (2011) depicts the appearance of CRPS
in the acute state; figure 2 depicts the
appearance of CRPS in the chronic state.
The pathophysiology of CRPS remains
unproven: however, many hypotheses
exist due to this disorder’s multiple system
dysfunction and the evidence is continuing
to progress. As the pathophysiologic
mechanisms of CRPS further advance,
treatment modalities will continue to
emerge in order for health care providers
to improve the outcomes for patients
suffering from CRPS.

Signs & Symptoms
CRPS may be caused spontaneously or by
an inciting injury that causes an abnormal
response to tissue injury. The signs and
symptoms of this multifactorial disorder
include:


severe pain,



Hyperalgesia



Hyperesthesia



atypical sudomotor activity



swelling of the affected limb



changes in skin color



cold and heat allodynia



motor or tropic changes which may
involve weakness, tremor, dystonia,
changes of the hair, skin and nails,
wasting away of tissue, skin or
muscle and bone thinning.



Patients with CRPS also present
with anxiety and depression
when compared to healthy
individuals.



The pain is neuropathic in nature
and is not limited to certain
dermatomes (Alexander et al.,
2014).



The pain caused by CRPS spreads
proximally over time and may
even develop on the opposite
limb.



Patients with longstanding CRPS
tend to perceive their affected
limb as larger than in reality and
report feelings of hostility
toward the limb, feeling as
though the limb is a separate
entity and causing the patient to
desire amputation of the
affected limb (Marinus et al.
2011).

Genetic association does appear to play a role in the pain disorder. CRPS phenotypes are
correlated with the human leukocyte antigen (HLA) system when two HLA alleles are present
at the loci (Watts & Kremer, 2011), associating CRPS with a genetic disposition.
The pathophysiology of CRPS remains elusive, but with multiple hypotheses. CRPS
involves interactions between the immune system and nervous system. CRPS also
involves both the peripheral and central nervous systems. The traumas usually identified
in the etiology of CRPS most likely begin with peripheral nociceptive overstimulation and
can eventually create and sustain the central sensitization that is indicated by the sensory
factors of the pain disorder (Hardin et al, 2013). Marinus et al. (2011) has identified
three major pathophysiological pathways: abnormal inflammatory mechanisms,
vasomotor dysfunction and maladaptive neuroplasticity.

Abnormal Inflammatory Mechanisms

Conclusion
CRPS is a painful disorder that effects more
than 50,000 new cases every year in the
United States (Watts & Kremer, 2011). The
research continues to progress for this
disorder as the pathophysiology continues
to unfold. Current evidence of multiple
mechanisms interconnected in the
pathophysiology of CRPS should provide
for additional discovery and more targeted
therapeutic interventions for the future.


Figure 3 below, provided by
Marinus et al. (2011),
represents clinical features and
proposed CRPS
pathophysiological mechanisms
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Alexander et al. (2012) identified significant changes in the plasma cytokines, chemokines,
and soluble receptors in individuals with CRPS that contribute to the inflammatory process.
Cytokines most likely act not only in the affected limb, but also in the spinal cord. Neurologic
inflammation is most likely the mechanism of post-junction signaling caused by weak
inactivation of neuropeptides and increased receptor availability (Marinus et al. 2011). The
pro-inflammatory cytokines are liable for the initiation and facilitation of inflammatory and
neuropathic pain and directly contribute to the extravasation of the limb, edema and
increased cytokine expression in CRPS.

Vasomotor Dysfunction
Vasomotor changes and hyperalgesia have been associated with sympathetic dysfunction. In
CRPS, the affected limb is initially warm due to vasoconstrictor neurons and further
progresses to become cold and a blue-like color. The up-regulation of alpha-adrenoreceptors
in cutaneous microvasculature has been identified as the mechanism of hypersensitivity
(Watts & Kremer, 2011). Watts and Kremer (2011) report that the vasoconstrictor
adrenoreceptors produce cool and pale skin and the adrenoreceptors on afferent nociceptive
fibers cause spontaneous pain. The result of this process is increased circulating
catecholamines that exacerbate sympathetically mediated symptoms. Furthermore, the
sustained vasoconstriction may be caused by changes in the endothelium that cause a
decreased ability to release endothelial nitric oxide (Marinus et al., 2011).

Complex regional pain syndrome, formerly
known as RSD or causalgia, requires more
education and knowledge pertaining to
the disease and the underlying processes
that are involved. The completed research
is presented to educate other medical
professionals on the pathophysiological
hypotheses behind CRPS, as well as
individuals that are subject to this pain
disorder.

Implications for Care

Underlying Pathophysiology

Maladaptive Neuroplasticity
Figure 1 Acute CRPS (Marinus et al., 2011)

Treatment of CRPS involves a combination
of modalities for both psychological and
pain symptoms. Interventional therapies
include peripheral nerve blocks, spinal cord
stimulator, pump implantation, chemical
and surgical sympathectomy and deep
brain stimulation. Pharmacological
therapies consist of bisphosphonate
compounds, phentolamine, systemic
steroids, antidepressants, opioids,
benzodiazepines and membrane stabilizers
in order to treat the symptoms of this
syndrome.

Maladaptive neuroplasticity could be explained by evidence of structural brain changes. D.
Lee et al. (2015) reported that CRPS patients revealed significantly decreased cortical
thickness in the right dorsolateral prefrontal cortex, implying that CRPS is accompanied by
cerebral atrophy that may contribute to the pathophysiology. In addition, Pleger et al.
(2014) found that CRPS patients have an increase in gray matter density in the dorsomedial
prefrontal cortex which is involved in coding emotional correlates of pain. This evidence
demonstrates that brain structure alterations in patients with CRPS are involved in
regulating cognitive processes including emotional behavior and pain perception.
The central nervous system (CNS) is affected by CRPS. Although not completely
understood, central sensitization may occur from lack of restraint of spinal and trigeminal
nociceptive neurons or enablement of nociceptive activity by excitatory neurons (Marinus
et al. 2011). Sensitization of the CNS can cause symptoms such as chronic pain,
hyperalgesia, allodynia and spreading of pain to nearby non-injured areas.

Figure 2 Chronic CRPS (Marinus et al., 2011)

M1=primary motor cortex. S1=primary somatosensory cortex.
SMA=supplementary motor cortex. IL=interleukin. TNF=tumor necrosis
factor. NGF=nerve growth factor. CGRP=calcitonin-gene-related
peptide. SP=substance P. NO=nitric oxide. ET=endothelin.
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